Neoepitopes - OmicsDI

Show results for

Unknown (253)
Genomics (61)
Proteomics (38)
Transcriptomics (27)
Other (2)
Genomic (1)

Organisms

Aerococcus urinae NBRC 15544 = CCUG 36881 (31)
Andropogon gerardi (31)
Bacteria (31)
Bartonella quintana JK 31 (31)
Canis lupus familiaris (31)
Cnidaria (31)
Ectopseudomonas oleovorans CECT 5344 (31)
Ensifer adhaerens (31)
Globicatella sanguinis (31)
Halictus scabiosae (31)
Human immunodeficiency virus 1 (31)
Mesocricetus auratus (31)
Methylohalobius crimeensis 10Ki (31)
Miscanthus x giganteus (31)
Mus musculus (31)
Panicum virgatum (31)
Pseudomonas aeruginosa SJTD-1 (31)
Rabies virus Nishigahara RCEH (31)
Rattus norvegicus (31)
Rattus rattus (31)
Rhodococcus jostii RHA1 (31)
Rhodopseudomonas palustris (31)
Schizosaccharomyces pombe 927 (31)
Shigella (31)
Sorghastrum nutans (31)
Staphylococcus aureus (31)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (31)
Streptomyces coelicolor A3(2) (31)
Homo sapiens (23)
Mus musculus (14)

Organisms

Homo sapiens (19)
Mus musculus (13)
Mus musculus musculus (1)

Repository

ENA (55)
geo (31)
pride (31)
MassIVE (6)
EGA (3)
biostudies-arrayexpress (1)
dbGaP (1)
iProX (1)

Tissue

Cell culture (8)
Blood (7)
B cell (4)
Lung (4)
Colon (3)
Dendritic cell (3)
Epithelial cell (3)
Liver (3)
Skin (3)
Spleen (3)
Bone marrow (2)
Cerebellum (2)
Heart (2)
Kidney (2)
Pancreas (2)
Peripheral blood mononuclear cell (2)
Testis (2)
Adrenal gland (1)
Aorta (1)
Bladder (1)
Blood plasma (1)
Brain (1)
Breast cancer cell line (1)
Cell suspension culture (1)
Conventional dendritic cell (1)
Fibroblast (1)
Gall bladder (1)
Gastric antrum (1)
Gastric fundus (1)
T cell (1)

Disease

Disease free (3)
Colon cancer (2)
Melanoma (2)
Non-small cell lung carcinoma (2)
Acute myeloid leukemia (1)
Breast cancer (1)
Cell type cancer (1)
Disease of metabolism (1)
Obesity (1)
Ovarian carcinoma (1)
Prostate cancer (1)
Renal cell carcinoma (1)
Rheumatoid arthritis (1)
Systemic lupus erythematosus (1)
Type 1 diabetes mellitus (1)

Technology Type

Mass Spectrometry (31)
Shotgun proteomics (15)
Affinity purification coupled with mass spectrometry proteomics (8)
Data-independent acquisition (4)
Bottom-up proteomics (3)
Top-down proteomics (3)
Data-dependent acquisition (2)
Immunopeptidomics (2)
ILLUMINA, Illumina HiSeq 2000 (1)
All-ion fragmentation (1)
SRM/MRM (1)
SWATH MS (1)

Instrument Platform

Orbitrap Fusion Lumos (3)
Q Exactive (2)
Illumina MiSeq (1)
Orbitrap Eclipse (1)
Q Exactive HF (1)
TimsTOF Pro 2 (1)
TimsTOF SCP (1)
TimsTOF Ultra (Bruker Daltonics timsTOF series) (1)

Publication Date

2025 (16)
2024 (13)
2021 (10)
2023 (9)
2026 (7)
2022 (6)
2020 (4)
2017 (2)
2019 (2)

First Public Date

2024 (15)
2025 (9)
2021 (7)
2026 (5)
2023 (5)
2022 (5)
2020 (3)
2017 (3)
2019 (2)
2018 (1)

Modification

Not available (1)

Study type

DNA-seq (1)

Release Date

2021 (41)
2022 (29)
2023 (28)
2024 (25)
2019 (25)
2020 (24)
2018 (24)
2025 (20)
2016 (14)
2017 (9)
2026 (5)
2015 (3)
2012 (2)
2010 (2)
2014 (1)
2011 (1)
2009 (1)

Lab affiliation

Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia (2)
German Cancer Reseach Center (DKFZ) (2)
Monash University (2)
Arthritis Research UK Career Development Fellow Institute of Aging and Chronic Disease University of Liverpool (1)
Calico Life Sciences (1)
Charité-University Medicine Berlin (1)
Children's Hospital of Phildelphia and University of Pennsylvania (1)
Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany (1)
Department of Peptid-based Immunotherapy, University and University Hospital TÃƒÆ’Ã‚Â¼bingen, Germany (1)
Department of Peptide-based Immunotherapy (1)
Department of Peptide-based Immunotherapy, University and University Hospital Tuebingen, Germany (1)
Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany (1)
Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany (lab head) (1)
Department of Pharmaceutical Sciences, University of Colorado - Anschutz Medical Campus, Aurora, CO, USA (1)
Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA; Department of Pathology, University of Massachusetts Medical School, Worcester, MA, USA. (1)
Department: Radiation Oncology; Weill Cornell Medicine: Englander Institute of Precision Medicine; USA. (1)
Dept. Oncology-Pathology, Scilifelab, Karolinska Institutet, Sweden (1)
Dept. of Computer Science, University of Tübingen Germany, Center for Bioinformatics, University of Tübingen, Germany, Quantitative Biology Center, University of Tübingen, Germany, Max Planck Institute for Developmental Biology, Germany, (1)
Division of Proteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany Heidelberg University, Medical Faculty, Heidelberg, Germany (1)
Head / Immunopeptidomics unit Department of Oncology UNIL/CHUV Ludwig Cancer Research Center Biopole III, Chemin des Boversses 155 Epalinges, 1066 Switzerland (1)
INCLIVA Biomedical Research Institute (1)
Mass Spectrometry/Proteomics Facility, Netherlands Cancer Institute, Amsterdam, Netherlands. (1)
Molecular Medicine Partnership Unit (MMPU), Heidelberg University & European Molecular Biology Laboratory (EMBL) Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University & Hopp Children’s Cancer Center, National Center for Tumor Diseases (NCT) (1)
NKI Proteomics Facility (1)
Radiation Oncology Department; Weill Cornell Medicine, NY, 10065 (1)
The Netherlands Cancer Institute Proteomics Facility, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands (1)
Translational Control and Metabolism, German Cancer Research Center (DKFZ), Heidelberg, Germany (1)
VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium. Department of Biomolecular Medicine, Ghent University, Ghent, Belgium. VIB Proteomics Core, VIB, Ghent, Belgium. (1)

Previous page
1 / 39
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 39
Next page

Sort by:

Relevance

Page size

An unbiased approach to defining bona fide tumor neoepitopes that mediate cancer immunity

PRJNA681865 | ENA

An unbiased approach to defining bona fide tumor neoepitopes that mediate cancer immunity

Identification of neoepitopes that are effective in cancer therapy is a major challenge in creating cancer vaccines. Here, using an entirely unbiased approach, we have queried all possible neoepitopes in a mouse cancer model and asked which of those are effective in mediating tumor rejection, and in...

ORGANISM(S): Mus musculus

2020-12-15 | GSE162432 | GEO

Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers.

Not available

S-EPMC8610152 | biostudies-literature

Intron retention is a source of neoepitopes in cancer.

Not available

S-EPMC6226333 | biostudies-literature

Predicting T cell recognition of MHC class I restricted neoepitopes.

Not available

S-EPMC6204999 | biostudies-literature

Circular RNAs as a potential source of neoepitopes in cancer.